Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 48(1); 2016 > Article
Original Article Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
Mina Suh, MD, PhD, Kui Son Choi, PhD, Boyoung Park, MD, PhD, Yoon Young Lee, MPH, Jae Kwan Jun, MD, PhD, Duk-Hyoung Lee, MD, PhD, Yeol Kim, MD, MPH
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2016;48(1):1-10.
DOI: https://doi.org/10.4143/crt.2014.204
Published online: April 15, 2015

National Cancer Control Institute, National Cancer Center, Goyang, Korea

Correspondence: Yeol Kim, MD, MPH Division of Cancer Management & Policy, National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea 
Tel: 82-31-920-1753 Fax: 82-31-920-2189 E-mail: drheat@ncc.re.kr
• Received: July 31, 2014   • Accepted: March 6, 2015

Copyright © 2016 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 18,055 Views
  • 245 Download
  • 93 Web of Science
  • 90 Crossref
  • 97 Scopus
next
  • Purpose
    The Korean National Cancer Screening Survey (KNCSS), a nationwide cross-sectional survey, has been conducted annually since 2004. The current study was conducted to report on the trends in screening rates among Korean men and women, and to evaluate policies regarding cancer screening programs implemented to reduce the burden of cancer.
  • Materials and Methods
    The current study used KNCSS data. The eligible study population included men aged 40-74 years and women aged 30-74 years with no cancer history. The lifetime screening rate, screening rate with recommendation, and changes in annual rates were calculated for five major cancers (i.e., stomach, liver, colorectal, breast, and cervix uteri).
  • Results
    The screening rates with recommendation increased by 4.2% (95% confidence interval [CI], 3.7% to 4.8%) annually for stomach cancer, 1.2% (95% CI, 0.1% to 2.4%) for liver cancer, 3.0% (95% CI, 1.8% to 4.1%) for colorectal cancer, 3.7% (95% CI, 2.7% to 4.8%) for breast cancer, and 1.3% (95% CI, 0.8% to 1.8%) for cervical cancer. In 2013, the screening rates with recommendation for stomach, liver, colorectal, breast, and cervical cancers were 73.6%, 33.6%, 55.6%, 59.7%, and 67.0%, respectively.
  • Conclusion
    Both the lifetime screening rates and screening rates with recommendation for the five above-mentioned cancers increased annually from 2004 to 2013.
Cancer is the leading cause of death in Korea, where more than 73,757 people died of cancer in 2012 [1]. The cancer incidence rate for all cancer sites combined increased by 3.4% per year (1.6% in males, 5.4% in females) from 1999 to 2011 [2]. Cancer screening allows for early cancer detection, before appearance of symptoms, which usually results in better outcomes. Therefore, screening reduces cancer mortality, and in some cases, cancer incidence. In Korea, both organized and opportunistic cancer screening are available. The organized cancer screening program is provided by the government. Opportunistic cancer screening programs include a variety of options in terms of the items screened, intervals between screenings, and target cancer type depending on individual decisions or recommendations from health care providers.
In 1999, the Korean government established the National Cancer Screening Program (NCSP) to provide organized cancer screening to reduce the burden of cancer. Since then, the target population and types of cancer covered by NCSP have been expanded. The NCSP provided Medical Aid recipients with free-of-charge screening for stomach, breast, and cervical cancer until 2001. Since 2002, National Health Insurance (NHI) beneficiaries in the lower 20% income stratum have been included in the NCSP. In 2003, NHI beneficiaries in the lower 30% income stratum and patients with one additional type of cancer (liver) were included, and patients with colorectal cancer were included in the NCSP in 2004. Since 2005, the NCSP has provided Medical Aid recipients and NHI beneficiaries in the lower half of the income stratum with screenings for five types of cancer (i.e., stomach, liver, colorectal, breast, and cervix uteri). NHI beneficiaries in the upper 50% income stratum receive screening services for the same five types of cancer from the NHI Corporation; however, they pay 10% of the screening cost [3-7]. The NCSP utilizes nationally implemented protocols that define a target population, screening interval, and follow-up strategies (Table 1). Here, we report the trends in overall screening rates associated with both the organized and opportunistic cancer screening programs among Korean men and women, and we evaluate policies on cancer screening programs implemented to reduce the burden of cancer.
The Korean National Cancer Screening Survey (KNCSS) data from 2004 to 2013 were used in the current study. The National Cancer Center has conducted the KNCSS annually since 2004 [8]. The KNCSS is a nationwide, population-based, cross-sectional survey. Stratified multistage, random sampling based on resident registration population data are collected according to geographical area, age, and sex. In the current study, the number of enumeration districts was designated in proportion to population size by sex, age, and geographical area, and the final study clusters were randomly selected. A total of 5 to 7 households in an urban area, and 10 to 12 households in a rural area were randomly chosen. The methods used for sampling were described in a previous study [9].
According to the protocols of the NCSP (Table 1), people older than 40 years of age are eligible to undergo gastric cancer screening; those older than 50 years of age are eligible to undergo colorectal cancer screening; women older than 40 years of age are eligible to undergo breast cancer screening; and women older than 30 years of age are eligible to undergo cervical cancer screening. Screening for liver cancer is restricted to individuals older than 40 years of age, in high-risk groups, such as patients who were carriers of hepatitis B virus or hepatitis C virus, or who have liver cirrhosis. Therefore, the target population in the current study comprised cancer-free men and women older than 40 and 30 years of age, respectively, in each year from 2004 to 2013.
In 2004, the data were collected using computer-assisted telephone interviews. From 2005 to 2013, the data were collected through face-to-face interviews conducted by a professional research agency. Subjects were recruited through door-to-door contact, and at least three attempts to contact each household were made. One person was selected from each household; if there was more than one eligible person in the household, the person whose date of birth was closest to the study date was selected. Informed consent was obtained from all study participants. The response rates ranged from 34.5% to 69.3% from 2005 to 2013.
Using a structured questionnaire, participants were asked about their experience with screening for five types of cancer (i.e., stomach, liver, colorectal, breast, and cervix uteri) and sociodemographic characteristics, including income level. The distributions of the sociodemographic characteristics of the study respondents for each year are shown in Table 2. The questions included “Have you ever undergone [cancer type] screening?” and “Which screening method have you experienced?” For the interval between screenings, the question was as follows: “When did you last undergo [cancer type] screening with this method?” To determine the reasons for undergoing or not undergoing screening, we asked “What are your primary reasons for undergoing screening or not undergoing screening?” Two types of cancer screening rates were measured in this study. “Lifetime screening” was defined as having ever undergone each type of screening test during his or her lifetime. The “screening rate with recommendation” category was assigned to participants who had undergone screening tests according to the procedure and interval of the NCSP (Table 1). However, for colorectal screening, respondents who underwent colonoscopy, double-contrast barium enema (DCBE), or fecal occult blood test (FOBT) within 5, 5, or 1 year, respectively, before 2009, and within 10, 5, and 1 year, respectively, after 2009 were considered to have undergone screening with recommendation.
Changes in the annual screening rates for lifetime screening and screening rates with recommendation were calculated as the annual percentage change (APC) within a 95% confidence interval (CI). The screening rates of each of the four cancers (stomach, colorectal, breast, and cervix uteri) were also calculated according to sex, age, and income. Because of an inadequate number of individuals within the high-risk group and unstable results that showed a wide 95% CI, the liver cancer screening rate was excluded from subgroup analysis. Monthly household income was subgrouped into three tertiles for each year. This study was approved by the National Cancer Center Institutional Review Board in Korea (approval number: NCCNCS-08-129).
The lifetime screening rates and screening rates with recommendation increased from 2004 onward. From 2004 to 2013, the lifetime screening rates increased annually by 3.9% for gastric cancer, 1.8% for liver cancer, 5.0% for colorectal cancer, 3.4% for breast cancer, and 0.3% for cervical cancer (Table 3). Significant increasing trends were observed in the lifetime screening rates for gastric, colorectal, and breast cancer, but not for liver or cervical cancer. The screening rates with recommendation increased annually by 4.2% for gastric cancer, 1.2% for liver cancer, 3.0% for colorectal cancer, 3.7% for breast cancer, and 1.3% for cervical cancer from 2004 to 2013. Significant increasing trends were observed in the screening rates with recommendation for all types of cancer. The trends and the APC of the screening rate differed according to the screening method used. The screening rate using upper endoscopy increased by more than 2-fold compared to that using an upper gastrointestinal series (4.2% and 1.7% per year, respectively). The colorectal cancer screening rate using FOBT or colonoscopy showed a more rapid increase than that using DCBE (2.7%, 2.2%, and 0.2% per year, respectively). Only the screening rate with recommendation using DCBE increased without statistical significance.
The screening rates according to sex, age, and income were calculated (Table 4, Figs. 1-3). In men, the screening rate with recommendation for stomach and colorectal cancer showed a steady increase (Fig. 1). In women, increasing trends were observed for stomach, colorectal, and cervical cancer from 2004 onward. For breast cancer, despite an increase in the screening rate with recommendation until 2012, the screening rate decreased rapidly by 11.2% from 2012 to 2013. For stomach and colorectal cancer, the screening rates with recommendation increased in all age groups (Fig. 2). In cases of breast cancer, an increasing tendency was observed before 2012, and the screening rate decreased from 2012 to 2013 in all age groups. The most rapid decrease in the screening rate with recommendation occurred for patients in their fifties with breast cancer in 2013 (18.3%). Although the screening rate with recommendation for cervical cancer in 2004 showed a significant difference according to age (highest rate, 70.5% vs. lowest rate, 27.9%), the screening rates by age group were similar in 2013. The screening rates for stomach and colorectal cancer increased steadily at all income levels, and differences in screening rates were smaller among all income groups than those in 2004 (Fig. 3). Screening rates for breast cancer showed an increasing pattern from 2004 to 2012, followed by a decreasing pattern in all income groups. The screening rate for cervical cancer was lower in the low-income group than in the middle- and high-income groups, whereas differences between groups showed a decrease.
Both the lifetime screening rates and screening rates with recommendation for the five above-mentioned cancers have increased since 2004. The lifetime screening rates for all cancer types with the exception of liver cancer exceeded 70% in 2013. The screening rates with recommendation are smaller than lifetime screening rates for each cancer. Repeated screening with the optimal time interval is required for early detection of cancer. Therefore, there is a need to undergo screening according to the recommended protocol. The screening rates with recommendation for gastric and breast cancer exceeded 70% in 2012, but those for breast cancer decreased to 59.7% in 2013. For breast cancer, the screening rate with recommendation increased by approximately 10% from 2011 to 2012, and declined by more than 10% from 2012 to 2013. In 2013, the screening rate with recommendation for breast cancer showed a trend similar to that in 2010 and 2011. The decreasing screening rates for breast cancer in all age groups appear to be the effect of broadcasted negative messages about breast cancer screening since 2012 in Korea. Also, in case of cervical cancer, the screening rate with recommendation for patients in their fifties decreased by 10.8% from 2012 to 2013. Therefore, continuous surveys and observations are needed to determine whether the decrease since 2012 will continue to be steady or is only a temporary decrease.
The trends of changes in cancer screening rates were analyzed by socio-demographic factors associated with cancer screening rate. The gaps of screening rates have recently decreased among age groups, and household income status in most of five cancers in NCSP. These trends suggested the positive effects in reducing the inequity regarding cancer screening by NCSP in Korea.
In the United States, the Guide to Community Preventive Services conducted and updated systematic reviews on the effectiveness of interventions to increase the screening rates for breast, cervical, and colorectal cancers [10,11]. This group recommends interventions involving one-on-one client education, providing client reminders, making screening more accessible and easier, reducing out-of-pocket costs, and performing provider assessment and feedback. Client reminders, increasing community access to screening, reducing out-of-pocket costs, and performing provider assessment and feedback have already been implemented in the Korean NCSP. However, the introduction of group or one-on-one education to clients should also be considered in Korea. Previous studies conducted in Japan reported a very high correlation between cancer screening rates and sending personal invitation letters regarding the strategies used in Japan [12]. Sending personal invitation letters has already been implemented in the NCSP system.
In the United Kingdom, where nationwide organized cancer screening has been implemented, the National Health System (NHS) breast screening program provides mammographic breast screening every 3 years. The 3-year coverage for breast cancer screening was 73.4% for women aged 45 to 74 years who underwent mammography in 2010-2011 [13]. In the United States, based on the National Health Interview Survey, the breast cancer screening rate using mammography among women aged ≥ 40 years was 51.2%, 53.0%, and 51.0% in 2005, 2008, and 2010, respectively [14]. Before 2005, the screening rate showed a slight decline of 3.4% from 2000 to 2005 [15]. The screening rates for breast cancer in Korean women in the same year were lower than those reported. In Japan, the screening rate for breast cancer was 14.2% in 2007, trending toward a gradual increase since the early 1990s [16].
In the United Kingdom, the 5-year cervical cancer screening coverage using the Pap smear test was 79.0% for women aged 25 to 49 in 2011-2012. However, there was a small drop in the 5-year coverage for women aged 50 to 64 years from 78.0% between 2010 and 2011, to 77.8% between 2011 and 2012 [17]. Based on the National Health Interview Survey conducted in the United States, the screening rate for cervical cancer in American women aged ≥ 18 years, who reported having undergone a Pap test within the past 3 years, was 79.6%, 78.3%, and 76.4% in 2005, 2008, and 2010, respectively [14]. The screening rate increased until 2000 and then fell. No changes in the absolute differences in the rates of cervical cancer screening according to education were observed [18]. The rates in the United Kingdom and United States were higher than those reported in the same year in Korea. In Japan, the screening rate for cervical cancer was 18.8% in 2007 [16], lower than that reported in Korea.
In Korea, both the lifetime screening rate and the screening rate with recommendation for colorectal cancer have shown a steady increase since 2004. In addition, the screening rate for colorectal cancer using FOBT or colonoscopy showed a more rapid increase than that using DCBE. Based on the National Health Interview Survey conducted in the United States, the prevalence of recent screening with either FOBT or endoscopy was 43.1% in 2005, 50.2% in 2008, and 56.4% in 2010 [14,19]. These rates are higher than those reported in the same year in Korea. In Korea, similar total colorectal cancer screening rates were reported for FOBT and colonoscopy, while in the United States a much higher screening rate was reported for colonoscopy than FOBT. In Japan, the screening rate for colorectal cancer was 18.8% in 2007, trending toward a gradual increase (APC, 0.5%) since the early 1990s [16]. These rates are lower than those reported in Korea.
The KNCSS conducted a 10-year nationwide survey in Korea and reported the screening rates for five types of cancer. However, this survey has some limitations. This study used self-reported data, which might have been affected by recall bias. However, many studies have reported high correlations between the rates derived from chart audits and patient surveys [20-22]. In addition, the response rate in this study ranged from 34.5% to 69.3%. Nonetheless, the results might have been affected by nonresponse bias. However, our response rate can be considered acceptable compared to other nationwide studies conducted in Korea, in which the response rates were greater than 50% [23,24]. In the current study, we used stratified multistage, random sampling according to geographical area, age, and sex, but not considering the economic level distribution. Despite some limitations, this nationwide, annual, population-based survey has been conducted for 10 years since 2004. Therefore, the data were sufficiently representative for investigation of the changes of cancer screening rates. The Korean government implemented the 10-Year Plan for Cancer Control; the first term was conducted from 1996 to 2005, and the second term from 2006 to 2015 [25]. One of the goals of the second term of the 10-Year Plan for Cancer Control was achievement of a 70% cancer screening rate with recommendation. In the current study, the screening rate with recommendation for stomach cancer exceeded 70% after 2012, and the screening rate for cervical cancer was close to reaching that goal. However, the screening rates for liver, colorectal, and breast cancer were lower than that goal in 2013. Therefore, a greater effort is needed to increase Korean cancer screening rates.
The KNCSS is conducted for systematic collection, analysis, and interpretation of data regarding the planning, implementation, and evaluation of nationwide cancer screening policies in Korea. As a result of these efforts, the screening rates for five types of cancer have shown a steady increase since 2004, the gaps of cancer screening rates according to socio-demographic factors have decreased, and those for some types of cancer have reached the goal of the 10-Year Plan for Cancer Control.

Conflict of interest relevant to this article was not reported.

Acknowledgements
This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310231).
Fig. 1.
Cancer screening rates with recommendation by sex, 2004-2013.
crt-2014-204f1.gif
Fig. 2.
Cancer screening rates with recommendation by age (yr), 2004-2013.
crt-2014-204f2.gif
Fig. 3.
Cancer screening rates with recommendation by household income level, 2004-2013. Monthly household income status classified by tertile.
crt-2014-204f3.gif
Table 1.
Cancer screening protocols issued by the National Cancer Screening Program (NCSP) in Korea
Cancer Target population Interval (yr) Test
Stomach Aged ≥ 40 years 2 Upper endoscopy or UGIa)
Liver High-risk groupb) aged ≥ 40 years 1 Ultrasonography and AFP
Colorectal Aged ≥ 50 years 1 FOBTc)
Breast Women aged ≥ 40 years 2 Mammography
Cervix uteri Women aged ≥ 30 years 2 Pap smear

UGI, upper gastrointestinal series; AFP, alpha-fetoprotein; FOBT, fecal occult blood test.

a) In the case of an abnormality on the UGI, endoscopy is recommended, and a biopsy is performed when an abnormality is found during endoscopy,

b) Patients at high risk for liver cancer include those with chronic hepatitis determined by serological evidence of infection with hepatitis B or C virus or liver cirrhosis,

c) In the case of an abnormality on FOBT, colonoscopy or a double-contrast barium enema is recommended, and a biopsy is performed when an abnormality is found during colonoscopy.

Table 2.
Distribution (%) of sociodemographic characteristics of the study respondents in the Korean National Cancer Screening Survey (KNCSS), 2004-2013
Survey year
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Total 3,592 2,028 2,030 2,021 2,038 2,000 4,056 4,100 4,140 4,100
Sex
 Male 42.4 41.0 40.2 39.4 40.6 41.0 41.4 41.9 42.0 42.3
 Female 57.6 59.0 59.8 60.6 59.4 59.1 58.6 58.1 58.0 57.7
Age (yr)
 30-39a) 14.1 12.0 17.6 17.8 17.7 17.0 15.9 15.5 15.3 14.4
 40-49 35.9 41.1 34.6 34.8 35.5 35.6 34.9 33.7 33.5 33.0
 50-59 22.7 28.6 21.8 21.6 24.7 25.2 27.3 28.5 28.7 29.8
 60-69 17.3 15.6 19.1 21.9 16.4 16.4 16.8 16.1 16.2 16.8
 ≥ 70 10.2 2.7 6.9 3.9 5.8 5.9 5.2 6.2 6.4 6.0
Education (yr)
 ≤ 8 25.8 16.4 20.9 18.2 13.6 15.1 8.1 8.2 9.7 5.2
 9-11 15.6 16.1 15.1 14.3 16.6 11.3 10.9 10.6 8.7 7.2
 12-15 34.3 47.6 44.7 46.3 46.6 46.8 52.1 52.5 50.6 54.1
 ≥ 16 22.6 18.5 17.6 19.1 20.7 24.9 28.8 28.7 30.9 33.5
Monthly household incomeb) ($)c)
 ≤ 999 25.3 11.4 14.1 10.0 9.3 9.4 4.6 4.5 4.6 2.4
 1,000-2,999 39.0 57.1 53.1 50.5 48.8 45.0 37.6 37.8 33.3 22.5
 ≥ 3,000 18.8 29.7 29.9 38.7 40.3 44.5 57.7 57.7 62.0 75.1
Marital status
 Married 88.2 92.8 89.6 89.8 90.3 90.2 91.5 91.5 94.2 91.8
 Not married 1.6 2.1 2.2 2.8 2.5 3.6 3.0 3.1 2.3 2.5
 Otherd) 9.5 5.1 8.3 7.4 7.2 6.3 5.5 5.5 3.6 5.7
Residential area
 Metropolitan 46.8 47.4 47.4 47.5 46.5 46.6 44.3 45.2 44.4 44.3
 Urban 53.2e) 39.8 40.5 40.3 44.2 44.0 42.2 41.6 36.3 42.0
 Rural 12.7 12.1 12.2 9.3 9.4 13.5 13.1 19.4 13.6
Health insurance typeb)
 National Health Insurance 90.8 95.8 94.5 96.7 95.9 95.3 96.5 96.7 98.3 96.9
 Medical Aid Program 6.0 4.2 4.2 3.2 3.8 4.3 3.5 3.3 1.7 3.1

a) Restricted to women aged 30-39 years,

b) Some row sums are not 100% each year because of missing data,

c) 1 USD=1,000 KRW,

d) Others: divorced or separated,

e) The question related to residential area did not distinguish between urban and rural areas in 2004.

Table 3.
Cancer screening rates for five major cancers in Korea, 2004-2013
Survey year
APC (95% CI)
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Lifetime screening rate (%)a)
 Stomach 52.0 48.5 53.5 55.3 65.0 65.1 76.7 76.2 77.9 80.0 3.9 (3.0 to 4.7)
 Liver 31.8 47.7 58.3 57.6 64.8 81.3 54.2 54.3 69.9 49.3 1.8 (-1.5 to 5.1)
 Colon and rectum 25.3 27.9 34.0 40.7 50.4 48.1 57.1 56.1 65.8 70.3 5.0 (4.3 to 5.7)
 Breast 55.9 57.4 60.2 66.4 72.7 78.1 79.5 79.0 82.9 83.1 3.4 (2.7 to 4.1)
 Cervix uteri 76.8 74.0 68.0 73.6 74.4 76.1 75.0 74.8 77.1 76.2 0.3 (-0.3 to 1.0)
Screening rate with recommendation (%)b)
 Stomachc) 39.2 39.4 43.3 45.6 53.5 56.9 65.1 64.6 70.9 73.6 4.2 (3.7 to 4.8)
  Upper endoscopy 32.4 32.9 33.5 37.8 44.8 49.3 58.9 58.1 63.3 64.4 4.2 (3.4 to 4.9)
  UGI series 13.0 13.1 15.2 20.4 21.1 19.5 24.9 25.3 26.4 24.9 1.7 (1.3 to 2.1)
 Liverd) 20.0 16.3 16.5 22.7 19.7 31.3 22.9 22.9 21.5 33.6 1.2 (0.1 to 2.4)
 Colon and rectume) 19.9 25.4 29.4 34.1 37.9 36.7 35.5 35.3 44.7 55.6 3.0 (1.8 to 4.1)
  Colonoscopy 14.4 12.4 16.8 19.5 19.1 23.4 23.3 23.6 30.1 35.2 2.2 (1.6 to 2.8)
  DCBE 2.8 4.1 5.3 8.7 7.0 6.1 6.1 6.0 3.8 7.0 0.2 (-0.3 to 0.6)
  FOBT 3.8 7.2 13.6 20.2 20.9 19.0 25.9 25.0 29.6 27.6 2.7 (1.9 to 3.5)
 Breastf) 33.2 38.4 40.6 45.8 49.3 55.2 61.6 60.4 70.9 59.7 3.7 (2.7 to 4.8)
 Cervix uterig) 58.3 57.0 54.9 57.0 59.9 63.9 62.9 62.4 67.9 67.0 1.3 (0.8 to 1.8)

APC, annual percent change; CI, confidence interval; UGI, upper gastrointestinal; DCBE, double-contrast barium enema; FOBT, fecal occult blood test.

a) Lifetime screening rate was defined as the proportion of respondents who ever underwent the screening test(s),

b) Screening rate with recommendation was defined as the proportion of respondents who fulfilled the screening recommendation criteria among the respondents in the targeted age group for the relevant cancer,

c) Respondents were restricted to men and women ≥ 40 years of age who had last undergone upper endoscopy or UGI series screening within a period of 2 years,

d) Respondents were restricted to men and women ≥ 40 years of age who were at high risk for liver cancer [hepatitis B virus surface antigen (+), hepatitis C virus antibody (+), or liver cirrhosis] who had last undergone screening with abdominal ultrasonography and serum alpha-fetoprotein within a period of 6 months,

e) Respondents were restricted to men and women ≥ 50 years of age who had last undergone screening with colonoscopy, DCBE, or FOBT within a period of 10, 5, or 1 year, respectively. However, before 2009, patients who underwent colonoscopy within a period of 5 years were considered to have undergone screening with recommendation,

f) Respondents were restricted to women ≥ 40 years of age who had last undergone screening with mammography within a period of 2 years,

g) Respondents were restricted to women ≥ 30 years of age who had last undergone screening with conventional cytology within a period of 2 years.

Table 4.
Cancer screening rates with recommendation by sex and age, 2004-2013
Survey year
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Stomach Male 37.4 37.4 40.3 42.7 50.1 52.3 63.5 63.5 69.8 72.4
Female 40.9 41.2 46.2 48.3 56.8 61.5 66.6 65.6 72.0 74.8
40-49 36.8 34.2 37.0 39.3 47.3 47.3 59.6 59.1 65.1 72.6
50-59 43.0 42.8 45.4 48.5 57.5 62.7 69.6 68.8 76.2 74.6
60-69 43.6 47.0 54.5 53.6 59.6 69.5 69.9 69.0 75.0 74.4
≥ 70 31.0 38.9 37.9 40.5 57.6 55.6 62.2 63.6 67.7 72.2
Colon and rectum Male 21.5 28.0 31.2 36.9 39.3 36.5 38.5 37.4 46.7 56.3
Female 18.5 23.0 27.8 31.8 40.1 36.8 32.7 33.3 42.8 54.9
50-59 19.4 23.5 26.0 30.7 40.0 35.5 33.3 32.7 42.9 54.7
60-69 21.9 28.1 37.1 38.5 40.7 38.7 38.4 38.3 48.0 57.4
≥ 70 17.6 29.7 18.6 29.1 35.6 35.9 37.3 39.6 44.4 55.0
Breast 40-49 37.6 35.8 40.7 44.2 42.1 51.0 59.4 57.4 69.0 63.8
50-59 38.0 47.5 45.0 52.0 56.9 58.2 66.7 66.7 77.6 59.2
60-69 30.5 33.0 44.5 46.5 51.1 65.5 59.1 58.1 68.5 56.5
≥ 70 15.6 16.7 20.9 25.5 54.4 38.8 51.9 54.0 59.6 50.8
Cervix uteri 30-39 64.0 56.6 53.2 51.7 55.0 55.6 57.1 56.0 55.4 63.6
40-49 70.5 62.4 64.0 66.7 60.1 70.8 67.2 66.6 75.1 72.6
50-59 61.3 62.3 57.3 61.5 69.8 70.9 70.8 70.2 77.6 66.8
60-69 38.1 39.7 53.1 51.2 57.9 64.9 58.8 58.3 65.2 64.7
≥ 70 27.9 25.0 26.4 38.3 54.4 41.8 45.7 47.9 54.1 62.0
  • 1. Korea Statistical Information Service [Internet]. Daejeon: Statistics Korea; 2014. [cited 2014 Jul 30]. Available from: http://kosis.kr
  • 2. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46:109–23. ArticlePubMedPMCPDF
  • 3. Lee YY, Oh DK, Choi KS, Jung KW, Lee HY, Jun JK. The current status of gastric cancer screening in Korea: report on the National Cancer Screening Programme, 2009. Asian Pac J Cancer Prev. 2011;12:3495–500. PubMed
  • 4. Noh DK, Choi KS, Jun JK, Lee HY, Park EC. Factors associated with attending the National Cancer Screening Program for liver cancer in Korea. Asian Pac J Cancer Prev. 2012;13:731–6. ArticlePubMed
  • 5. Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191–8. ArticlePubMedPMCPDF
  • 6. Oh DK, Shim JI, Han M, Kim Y, Lee HY, Jun JK, et al. Breast cancer screening in Korean women: report of the National Cancer Screening Program in 2008. J Breast Cancer. 2010;13:299–304. Article
  • 7. Lee YH, Choi KS, Lee HY, Jun JK. Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009. J Gynecol Oncol. 2012;23:16–21. ArticlePubMedPMC
  • 8. Suh M, Choi KS, Lee YY, Park B, Jun JK. Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev. 2013;14:6459–63. ArticlePubMed
  • 9. Lee HY, Park EC, Jun JK, Hahm MI, Jung KW, Kim Y, et al. Trends in socioeconomic disparities in organized and opportunistic gastric cancer screening in Korea (2005-2009). Cancer Epidemiol Biomarkers Prev. 2010;19:1919–26. ArticlePubMed
  • 10. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;43:97–118. ArticlePubMed
  • 11. Baron RC, Rimer BK, Coates RJ, Kerner J, Mullen PD, Chattopadhyay S, et al. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. Am J Prev Med. 2008;35(1 Suppl):S26–33. ArticlePubMed
  • 12. Sano H, Goto R, Hamashima C. What is the most effective strategy for improving the cancer screening rate in Japan? Asian Pac J Cancer Prev. 2014;15:2607–12. ArticlePubMed
  • 13. NHS Breast Screening Programme: annual review 2012 [Internet]. Sheffield: NHS Breast Screening Programme; 2012. [cited 2014 Jul 30]. Available from: http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbspannualreview2012.pdf
  • 14. Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014;64:30–51. ArticlePubMed
  • 15. National Cancer Institute. Cancer trends progress report: 2011/2012 update [Internet]. Bethesda, MD: National Cancer Institute; 2012. [cited 2014 Jul 30]. Available from: http://progressreport.cancer.gov/sites/default/files/archive/report2011.pdf
  • 16. Yoshida M, Kondo K, Tada T. The relation between the cancer screening rate and the cancer mortality rate in Japan. J Med Invest. 2010;57:251–9. ArticlePubMed
  • 17. NHS Cervical Screening Programme: annual review 2012 [Internet]. Sheffield: NHS Cancer Screening Programme; 2012. [cited 2014 Jul 30]. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/cervical-annual-review-2012.pdf
  • 18. National Cancer Institute. Cancer trends progress report: 2011/2012 update. Cervical cancer screening 2012 [Internet]. Bethesda, MD: National Cancer Institute; 2012. [cited 2014 Jul 30]. Available from: http://progressreport.cancer.gov/sites/default/files/archive/report2011.pdf
  • 19. National Cancer Institute. Cancer trends progress report: 2011/2012 update. Colorectal cancer screening 2012 [Internet]. Bethesda, MD: National Cancer Institute; 2012. [cited 2014 Jul 30]. Available from: http://progressreport.cancer.gov/sites/default/files/archive/report2011.pdf
  • 20. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev. 2003;12(11 Pt 1):1182–7. PubMed
  • 21. Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol. 2007;166:130–6. ArticlePubMed
  • 22. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85:795–800. ArticlePubMedPMC
  • 23. Ock SM, Choi JY, Cha YS, Lee J, Chun MS, Huh CH, et al. The use of complementary and alternative medicine in a general population in South Korea: results from a national survey in 2006. J Korean Med Sci. 2009;24:1–6. ArticlePubMedPMC
  • 24. Park B, Lee YK, Cho LY, Go UY, Yang JJ, Ma SH, et al. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. J Korean Med Sci. 2011;26:711–9. ArticlePubMedPMC
  • 25. Han MA, Choi KS, Park JH, Moore MA, Park EC. Midcourse evaluation of the second-term 10-year plan for cancer control in Korea. Asian Pac J Cancer Prev. 2011;12:327–33. PubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Nomogram for pre-procedural prediction of lymph node metastasis in patients with submucosal early gastric cancer
      Wenhao Yu, Zijie Xu, Ben Li, Mengli Zi, Jun Ren, Wei Wang, Qiannan Sun, Qi Zhang, Daorong Wang
      Surgical Endoscopy.2025; 39(3): 1661.     CrossRef
    • Diagnostic performance of abbreviated non-contrast MRI for liver metastases in patients with newly diagnosed breast cancer
      Taewon Han, Jaeseung Shin, Seungchul Han, Kyoung Doo Song, Honsoul Kim
      Clinical Imaging.2025; 121: 110461.     CrossRef
    • Mammographic density as a predictor of invasive breast cancer and ductal carcinoma in situ in over six million South Korean women
      Sung Hun Kim, Ga Eun Park, Kimberly A. Bertrand, Dale P. Sandler, Kyungdo Han, Yong‐Moon Mark Park
      Breast Cancer Research and Treatment.2025; 211(2): 341.     CrossRef
    • Utilization of colorectal cancer screening tests: a systematic review and time trend analysis of nationally representative data
      Idris Ola, Rafael Cardoso, Michael Hoffmeister, Hermann Brenner
      eClinicalMedicine.2024; 75: 102783.     CrossRef
    • Population‐based evaluation of disparities in stomach cancer by nativity among Asian and Hispanic populations in California, 2011–2015
      Eunjung Lee, Kai‐Ya Tsai, Juanjuan Zhang, Amie E. Hwang, Dennis Deapen, Jennifer J. Koh, Eric S. Kawaguchi, James Buxbaum, Sang Hoon Ahn, Lihua Liu
      Cancer.2024; 130(7): 1092.     CrossRef
    • Association between Socioecological Status, Nutrient Intake, and Cancer Screening Behaviors in Adults Aged 40 and Over: Insights from the Eighth Korea National Health and Nutrition Examination Survey (KNHANES, 2019)
      Seungpil Jeong, Yean-Jung Choi
      Nutrients.2024; 16(7): 1048.     CrossRef
    • Socioeconomic Disparities in Six Common Cancer Survival Rates in South Korea: Population-Wide Retrospective Cohort Study
      JinWook Lee, JuWon Park, Nayeon Kim, Fatima Nari, Seowoo Bae, Hyeon Ji Lee, Mingyu Lee, Jae Kwan Jun, Kui Son Choi, Mina Suh
      JMIR Public Health and Surveillance.2024; 10: e55011.     CrossRef
    • Gastric Cancer Screening: Intention to Adhere and Patients' Perspective
      João Carlos Silva, Mário Dinis‐Ribeiro, Fernando Tavares, Diogo Libânio
      Helicobacter.2024;[Epub]     CrossRef
    • Breast Cancer Statistics in Korea, 2021
      Chihwan David Cha, Chan Sub Park, Hee-Chul Shin, Jaihong Han, Jung Eun Choi, Joo Heung Kim, Kyu-Won Jung, Sae Byul Lee, Sang Eun Nam, Tae In Yoon, Young-Joon Kang, Zisun Kim, So-Youn Jung, Hyun-Ah Kim
      Journal of Breast Cancer.2024; 27(6): 351.     CrossRef
    • Role of breast cancer screening in the overdiagnosis of thyroid cancer: results from a cross-sectional nationwide survey
      Eunhye Lee, Sung Hoon Jeong, Chung Mo Nam, Jae Kwan Jun, Eun-Cheol Park
      BMC Women's Health.2023;[Epub]     CrossRef
    • Underuse of Gastric Cancer Screening Services among Koreans with Type 2 Diabetes
      Kumban Walter Chuck, Seri Hong, Yunhwan Lee
      Healthcare.2023; 11(7): 927.     CrossRef
    • Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level
      Jai Min Ryu, Danbee Kang, Juhee Cho, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Se Kyung Lee, Yeon Jin Kim, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Ji-Yeon Kim, Hyunjong Lee, Mira Kang, Jong Han Yu
      Journal of Breast Cancer.2023; 26(2): 126.     CrossRef
    • Breast Cancer Statistics in Korea, 2019
      Jung Eun Choi, Zisun Kim, Chan Sub Park, Eun Hwa Park, Sae Byul Lee, Se Kyung Lee, Young Jin Choi, Jaihong Han, Kyu-Won Jung, Hee Jeong Kim, Hyun-Ah Kim
      Journal of Breast Cancer.2023; 26(3): 207.     CrossRef
    • Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: Implication to cancer control
      Cham Thi Nguyen, Insang Song, Inkyung Jung, Yoon‐Jung Choi, Sun‐Young Kim
      Cancer Medicine.2023; 12(16): 17418.     CrossRef
    • Human papillomavirus (HPV) self-sampling to encourage the uptake of cervical screening
      Aslam Shiraz, Roberta Schiemer, Helen Staley, Tomomi Matsushita, Takeshi Hasegawa, Andrew Bryant, Eisuke Inoue, Nagayasu Egawa, Ketankumar B Gajjar
      Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef
    • Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kui Son Choi
      Epidemiology and Health.2023; 45: e2023086.     CrossRef
    • Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis
      Raquel Ortigão, Gonçalo Figueirôa, Leonardo Frazzoni, Pedro Pimentel-Nunes, Cesare Hassan, Mário Dinis-Ribeiro, Lorenzo Fuccio, Diogo Libânio
      Endoscopy.2022; 54(09): 892.     CrossRef
    • Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom
      Richeek Pradhan, Oriana Yu, Robert W. Platt, Laurent Azoulay
      Diabetes Research and Clinical Practice.2022; 185: 109229.     CrossRef
    • Korean American Immigrant Women’s Perceived Breast Cancer Risk and Prevention Beliefs: A Qualitative Study
      Mi Hwa Lee, Deeonna Farr, Sohye Lee
      Journal of Transcultural Nursing.2022; 33(3): 306.     CrossRef
    • Income Disparities in Cancer Screening: A Cross-Sectional Study of the Korean National Health and Nutrition Examination Survey, 2013–2019
      Vasuki Rajaguru, Tae Hyun Kim, Jaeyong Shin, Sang Gyu Lee
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Gastric cancer screening: a systematic review and meta-analysis
      Lídia Faria, João Carlos Silva, Marta Rodríguez-Carrasco, Pedro Pimentel-Nunes, Mário Dinis-Ribeiro, Diogo Libânio
      Scandinavian Journal of Gastroenterology.2022; 57(10): 1178.     CrossRef
    • Psychometric properties of a Chinese version of four-factor colorectal cancer screening belief scale
      Liu Yang, Rui Zhao, Shan Li, Chaona Ji, Jiexiong Qin, Yalan Song, Xiaodan Wu
      Asia-Pacific Journal of Oncology Nursing.2022; 9(9): 100081.     CrossRef
    • Colonoscopy decreases mortality in colorectal cancer patients compared with fecal immunochemical test
      Soo‐Yoon Sung, Hyun Ho Choi, Sukil Kim, Bo Ram Park, Young Ki Kim, Hyung‐Keun Kim, Young‐Seok Cho, Sang Woo Kim, Sung Soo Kim, Hiun‐Suk Chae
      Journal of Gastroenterology and Hepatology.2022; 37(10): 1991.     CrossRef
    • Changes in cancer screening before and during COVID‐19: findings from the Korean National Cancer Screening Survey 2019 and 2020
      Thao Thi Kim Trinh, Yun Yeong Lee, Mina Suh, Jae Kwan Jun, Kui Son Choi
      Epidemiology and Health.2022; 44: e2022051.     CrossRef
    • Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer Society
      Young-Joon Kang, Se Jeong Oh, Hoon Choi, Shijin Cho, Chang-Hyun Shin, Chaiwon Kim, Joohyun Woo, JungSun Lee, Heung Kyu Park, Han-Byoel Lee, Woo Chul Noh, Yong-Seok Kim
      Breast Cancer Research and Treatment.2021; 186(1): 125.     CrossRef
    • A Prospective Validation and Observer Performance Study of a Deep Learning Algorithm for Pathologic Diagnosis of Gastric Tumors in Endoscopic Biopsies
      Jeonghyuk Park, Bo Gun Jang, Yeong Won Kim, Hyunho Park, Baek-hui Kim, Myeung Ju Kim, Hyungsuk Ko, Jae Moon Gwak, Eun Ji Lee, Yul Ri Chung, Kyungdoc Kim, Jae Kyung Myung, Jeong Hwan Park, Dong Youl Choi, Chang Won Jung, Bong-Hee Park, Kyu-Hwan Jung, Dong-
      Clinical Cancer Research.2021; 27(3): 719.     CrossRef
    • Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans
      Joo Hyun Lim, Ji Hyun Song, Su Jin Chung, Goh Eun Chung, Joo Sung Kim
      BMC Cancer.2021;[Epub]     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004–2018
      Seri Hong, Yun Yeong Lee, Jaeho Lee, Yeol Kim, Kui Son Choi, Jae Kwan Jun, Mina Suh
      Cancer Research and Treatment.2021; 53(2): 330.     CrossRef
    • Breast Cancer Statistics in Korea, 2018
      Sang Yull Kang, Sae Byul Lee, Yoo Seok Kim, Zisun Kim, Hyun Yul Kim, Hee Jeong Kim, Sungmin Park, Soo Youn Bae, Kwanghyun Yoon, Se Kyung Lee, Kyu-Won Jung, Jaihong Han, Hyun Jo Youn
      Journal of Breast Cancer.2021; 24(2): 123.     CrossRef
    • Endoscopic instruments and techniques in endoscopic submucosal dissection for early gastric cancer
      Mitsuru Esaki, Eikichi Ihara, Takuji Gotoda
      Expert Review of Gastroenterology & Hepatology.2021; 15(9): 1009.     CrossRef
    • Trends of cutaneous basal cell carcinoma, squamous cell carcinoma, and melanoma among the Chinese, Malays, and Indians in Singapore from 1968-2016
      Choon Chiat Oh, Aizhen Jin, Woon-Puay Koh
      JAAD International.2021; 4: 39.     CrossRef
    • Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program
      Cam Nhung Bui, Seri Hong, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Effectiveness of Hepatocellular Carcinoma Surveillance and an Optimal Surveillance Interval: Nationwide Cohort of Korea
      Heejin Bae, Sang Ah Lee, Jong Won Choi, Shin Hye Hwang, Sumi Park, Mi-Suk Park
      Yonsei Medical Journal.2021; 62(8): 758.     CrossRef
    • Convolutional neural network‐based object detection model to identify gastrointestinal stromal tumors in endoscopic ultrasound images
      Chang Kyo Oh, Taewan Kim, Yu Kyung Cho, Dae Young Cheung, Bo‐In Lee, Young‐Seok Cho, Jin Il Kim, Myung‐Gyu Choi, Han Hee Lee, Seungchul Lee
      Journal of Gastroenterology and Hepatology.2021; 36(12): 3387.     CrossRef
    • Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
      YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Gastric Cancer.2020; 23(3): 497.     CrossRef
    • Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea
      Dong Wook Shin, Jonghan Yu, Juhee Cho, Se Kyung Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Jung Eun Yoo, Kyoung Eun Yeob, Yeon Yong Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Cancer.2020; 126(7): 1522.     CrossRef
    • Adaptation and validation of the health belief model scale for colorectal cancer screening
      Shin‐Young Lee, Eunice E. Lee, Young Sun Rhee, Eun Young Yang, Jeong Ha Shin, Seonah Lee
      Nursing & Health Sciences.2020; 22(2): 355.     CrossRef
    • Association of Screening by Thyroid Ultrasonography with Mortality in Thyroid Cancer: A Case–Control Study Using Data from Two National Surveys
      Jae Kwan Jun, Soon-Young Hwang, Seri Hong, Mina Suh, Kui Son Choi, Kyu-Won Jung
      Thyroid.2020; 30(3): 396.     CrossRef
    • Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea
      Jeongeun Hwang, Hyunjin Bae, Seunghyun Choi, Hahn Yi, Beomseok Ko, Namkug Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea
      Won Sohn, Young-Sun Lee, Jae Geun Lee, Jihyun An, Eun Sun Jang, Dong Ho Lee, Dong Hyun Sinn
      Journal of Liver Cancer.2020; 20(1): 53.     CrossRef
    • Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry
      Sang Yull Kang, Yoo Seok Kim, Zisun Kim, Hyun Yul Kim, Hee Jeong Kim, Sungmin Park, Soo Youn Bae, Kwang Hyun Yoon, Sae Byul Lee, Se Kyung Lee, Kyu-Won Jung, Jaihong Han, Hyun Jo Youn
      Journal of Breast Cancer.2020; 23(2): 115.     CrossRef
    • Personality Types as Predictors of Breast Cancer Screening Compliance in Korean Patients: A Mixed-Method Approach
      Kyungmin Kim, Eunhee Sohn, Hyo-Deog Rim, Seoyoung Jang, Jungmin Woo
      Psychiatry Investigation.2020; 17(11): 1079.     CrossRef
    • Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea
      E Hwa Yun, Seri Hong, Eun Young Her, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Cancers.2020; 13(1): 81.     CrossRef
    • Early Surgical and Long-term Oncological Outcomes of Totally Laparoscopic Near-total Gastrectomy in >150 Cases
      Eun Ju Shin, Chung Sik Gong, Byung Sik Kim, Seon Ok Kim, Chang Seok Ko, Hee Sung Kim
      Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2020; 30(6): 529.     CrossRef
    • Comparisons of Papanicolaou Utilization and Cervical Cancer Detection between Rural and Urban Women in Taiwan
      Chiu-Ming Yang, Fung-Chang Sung, Chao-Song Hsue, Chih-Hsin Muo, Shu-Wei Wang, Shwn-Huey Shieh
      International Journal of Environmental Research and Public Health.2020; 18(1): 149.     CrossRef
    • Long-term changes in the metabolic and nutritional parameters after gastrectomy in early gastric cancer patients with overweight
      Jisun Lim, Moon-Won Yoo, Seo Young Kang, Hye Soon Park
      Asian Journal of Surgery.2019; 42(1): 386.     CrossRef
    • Increased Risk of Osteoporosis in Gastric Cancer Survivors Compared to General Population Control: A Study with Representative Korean Population
      Su-Min Jeong, Dong Wook Shin, Ji Eun Lee, Sang-Man Jin, Sung Kim
      Cancer Research and Treatment.2019; 51(2): 530.     CrossRef
    • Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea
      Young-Tak Kim, Beatriz Serrano, Jae-Kwan Lee, Hyunju Lee, Shin-Wha Lee, Crystal Freeman, Jin-Kyoung Oh, Laia Alemany, Francesc-Xavier Bosch, Laia Bruni
      Papillomavirus Research.2019; 7: 26.     CrossRef
    • Self-perceptions of body weight status according to age-groups among Korean women: A nationwide population-based survey
      Boyoung Park, Ha Na Cho, Eunji Choi, Da Hea Seo, Sue Kim, Yeong-Ran Park, Kui Son Choi, Yumie Rhee, Yongjoo Kim
      PLOS ONE.2019; 14(1): e0210486.     CrossRef
    • Employment conditions and use of gastric cancer screening services in Korea: a nationwide survey
      Hye-Young Shim, Jae Kwan Jun, Ji-Yeon Shin
      BMC Public Health.2019;[Epub]     CrossRef
    • Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study
      Jin-Kyoung Oh, Hwa Young Choi, Minji Han, Jae-Kwan Lee, Kyung-Jin Min, Moran Ki
      Sexually Transmitted Infections.2019; 95(4): 292.     CrossRef
    • Effect of Different Types of Mammography Equipment on Screening Outcomes: A Report by the Alliance for Breast Cancer Screening in Korea
      Bo Hwa Choi, Eun Hye Lee, Jae Kwan Jun, Keum Won Kim, Young Mi Park, Hye-Won Kim, You Me Kim, Dong Rock Shin, Hyo Soon Lim, Jeong Seon Park, Hye Jung Kim
      Korean Journal of Radiology.2019; 20(12): 1638.     CrossRef
    • Age and sex subgroups vulnerable to copycat suicide: evaluation of nationwide data in South Korea
      Hahn Yi, Jeongeun Hwang, Hyun-Jin Bae, Namkug Kim
      Scientific Reports.2019;[Epub]     CrossRef
    • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
      Sunghwan Suh, Kwang-Won Kim
      Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
    • Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016
      Ha Na Cho, Eunji Choi, Da Hea Seo, Boyoung Park, Sohee Park, Juhee Cho, Sue Kim, Yeong-Ran Park, Yumie Rhee, Kui Son Choi
      BMJ Open.2019; 9(4): e026366.     CrossRef
    • Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea
      Nhung Cam Bui, Ha Na Cho, Yoon Young Lee, Mina Suh, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi
      Cancer Research and Treatment.2018; 50(2): 416.     CrossRef
    • Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea
      Jae Kwan Jun, Na Young Sung, Seung Hoon Song, Seri Hong, Mi-Ae Jang, Junghan Song, Jeong-Ho Kim, Won-Ki Min, You Kyoung Lee
      Annals of Laboratory Medicine.2018; 38(3): 249.     CrossRef
    • Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
      Dae Ho Kim, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Young-Hak Cho, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee
      Gut and Liver.2018; 12(2): 183.     CrossRef
    • Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea
      Jae Myung Cha, Mina Suh, Min Seob Kwak, Na Young Sung, Kui Son Choi, Boyoung Park, Jae Kwan Jun, Sang-Hyun Hwang, Do-Hoon Lee, Byung Chang Kim, You Kyoung Lee, Dong Soo Han
      American Journal of Gastroenterology.2018; 113(4): 611.     CrossRef
    • The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
      Anaïs Chauvin, Chang-Shu Wang, Sameh Geha, Perrine Garde-Granger, Alex-Ane Mathieu, Vincent Lacasse, François-Michel Boisvert
      Clinical Proteomics.2018;[Epub]     CrossRef
    • Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database
      Aesun Shin, Young‐Joo Won, Hye‐Kyung Jung, Hyun‐Joo Kong, Kyu‐Won Jung, Chang‐Mo Oh, Sunho Choe, Jihyun Lee
      Journal of Gastroenterology and Hepatology.2018; 33(12): 1961.     CrossRef
    • Estimation of the medical need for carbon-ion radiotherapy in Korea
      Ilsung Cho, Young Seok Seo, WonGyun Jung, Mi-sook Kim
      Journal of Radiation Research.2018; 59(5): 588.     CrossRef
    • Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea
      Chang-Mo Oh, Hyunsoon Cho, Young-Joo Won, Hyun-Joo Kong, Yun Ho Roh, Ki-Heon Jeong, Kyu-Won Jung
      Cancer Research and Treatment.2018; 50(3): 729.     CrossRef
    • Guideline Adherence to Colonoscopic Surveillance Intervals after Polypectomy in Korea: Results from a Nationwide Survey
      Seri Hong, Mina Suh, Kui Son Choi, Boyoung Park, Jae Myung Cha, Hyun-Soo Kim, Jae Kwan Jun, Dong Soo Han
      Gut and Liver.2018; 12(4): 426.     CrossRef
    • Disparities in Cervical Cancer Screening Among Women With Disabilities: A National Database Study in South Korea
      Dong Wook Shin, Jeong-Won Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park
      Journal of Clinical Oncology.2018; 36(27): 2778.     CrossRef
    • Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea
      Ji-Yeon Shin, Kui Son Choi, Mina Suh, Boyoung Park, Jae Kwan Jun
      BMC Cancer.2018;[Epub]     CrossRef
    • Socioeconomic Inequalities in Stomach Cancer Screening in Korea, 2005–2015: After the Introduction of the National Cancer Screening Program
      Eun-young Lee, Yoon Young Lee, Mina Suh, Eunji Choi, Tran Thi Xuan Mai, Hyunsoon Cho, Boyoung Park, Jae Kwan Jun, Yeol Kim, Jin Kyung Oh, Moran Ki, Kui Son Choi
      Yonsei Medical Journal.2018; 59(8): 923.     CrossRef
    • Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults
      Su‐Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung Min Kim, Gyeongsil Lee, Seong Yong Park, Yeon‐Yong Kim, Joung Sik Son, Jae‐Moon Yun, Sang Min Park
      Journal of the American Heart Association.2018;[Epub]     CrossRef
    • Beliefs and Intentions to Undergo Lung Cancer Screening among Korean Males
      Nhung Cam Bui, Yoon Young Lee, Mina Suh, Boyoung Park, Hyunsoon Cho, Yeol Kim, Kui Son Choi
      Cancer Research and Treatment.2018; 50(4): 1096.     CrossRef
    • Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005–2015
      Eunji Choi, Yoon Young Lee, Mina Suh, Eun Young Lee, Tran Thi Xuan Mai, Moran Ki, Jin-Kyoung Oh, Hyunsoon Cho, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi
      Yonsei Medical Journal.2018; 59(9): 1026.     CrossRef
    • Assessment of results of the mammography screenıngs among women older than 40 years ın a resıdentıal area
      Sevil Biçer, Gökçe Demir, Ayla Ünsal, Yasemin Şadiye Ceyhan
      International Physical Medicine & Rehabilitation Journal.2018;[Epub]     CrossRef
    • The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil
      Sheila Cristina Rocha-Brischiliari, Rosana Rosseto de Oliveira, Luciano Andrade, Adriano Brischiliari, Angela Andreia França Gravena, Maria Dalva de Barros Carvalho, Sandra Marisa Pelloso, Aamir Ahmad
      PLOS ONE.2017; 12(1): e0168950.     CrossRef
    • Differences in the survival rates of older patients with colorectal cancers in 2003 and 2009
      Je-Wook Shin, Byung Kwan Park, Min Jung Kim, Bun Kim, Byung Chang Kim, Sung Chan Park, Kyung Su Han, Dae Kyung Sohn, Jae Hwan Oh
      Annals of Surgical Treatment and Research.2017; 92(4): 191.     CrossRef
    • Analysis of Participant Factors That Affect the Diagnostic Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea
      Young Joong Kim, Eun Hye Lee, Jae Kwan Jun, Dong-Rock Shin, Young Mi Park, Hye-Won Kim, Youme Kim, Keum Won Kim, Hyo Soon Lim, Jeong Seon Park, Hye Jung Kim, Hye-Mi Jo
      Korean Journal of Radiology.2017; 18(4): 624.     CrossRef
    • Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014
      Seung-Hyuk Shim, Hyeongsu Kim, In-Sook Sohn, Han-Sung Hwang, Han-Sung Kwon, Sun Joo Lee, Ji Young Lee, Soo-Nyung Kim, Kunsei Lee, Sounghoon Chang
      Journal of Gynecologic Oncology.2017;[Epub]     CrossRef
    • Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial
      Young-Il Kim, Mi-Jung Kim, Sook Ryun Park, Hark Kyun Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Gwang Ha Kim, Moo In Park, Byung-Ho Nam, Young Iee Park, Il Ju Choi
      Journal of Gastric Cancer.2017; 17(2): 120.     CrossRef
    • Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007–2012
      Eun-Ae Lee, Jinyoung Shin, Eun-Joo Hwang, Jung-Woong Lee
      Korean Journal of Family Medicine.2017; 38(3): 116.     CrossRef
    • Why Do Some People Choose Opportunistic Rather Than Organized Cancer Screening? The Korean National Health and Nutrition Examination Survey (KNHANES) 2010-2012
      Myung-Il Hahm, Hsueh-Fen Chen, Thaddeus Miller, Liam O’Neill, Hoo-Yeon Lee
      Cancer Research and Treatment.2017; 49(3): 727.     CrossRef
    • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
      Jong-Myon Bae
      Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
    • The association between peptic ulcer diseases and mental health problems
      Young Bok Lee, Jihan Yu, Hyun Ho Choi, Bu Seok Jeon, Hyung-Keun Kim, Sang-Woo Kim, Sung Soo Kim, Yong Gyu Park, Hiun Suk Chae
      Medicine.2017; 96(34): e7828.     CrossRef
    • Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
      Kumban Walter Chuck, Minji Hwang, Kui Son Choi, Mina Suh, Jae Kwan Jun, Boyoung Park
      Epidemiology and Health.2017; 39: e2017036.     CrossRef
    • Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea
      Hye Young Shin, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi
      BMC Cancer.2017;[Epub]     CrossRef
    • Stomach Cancer Disparity among Korean Americans by Tumor Characteristics: Comparison with Non-Hispanic Whites, Japanese Americans, South Koreans, and Japanese
      Eunjung Lee, Lihua Liu, Juanjuan Zhang, Mariana C. Stern, Afsaneh Barzi, Amie Hwang, Andre E. Kim, Ann S. Hamilton, Anna H. Wu, Dennis Deapen
      Cancer Epidemiology, Biomarkers & Prevention.2017; 26(4): 587.     CrossRef
    • Laparoscopic Proximal Gastrectomy with Double-Tract Reconstruction by Intracorporeal Anastomosis with Linear Staplers
      Kun Yang, Hui Jae Bang, Moneer E. Almadani, Donna Marie Dy-Abalajon, You-Na Kim, Kun Ho Roh, Seung Hyun Lim, Taeil Son, Hyoung-Il Kim, Sung Hoon Noh, Woo Jin Hyung
      Journal of the American College of Surgeons.2016; 222(5): e39.     CrossRef
    • The clinical utilization of radiation therapy in Korea between 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
      Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
    • How Can We Propagate the National Endoscopy Quality Improvement Program and Improve the Quality of Endoscopic Screening?
      Dong-Hoon Yang
      Gut and Liver.2016; 10(5): 657.     CrossRef
    • Women Who Sleep More Have Reduced Risk of Peptic Ulcer Disease; Korean National Health and Nutrition Examination Survey (2008–2009)
      Sun-Hye Ko, Myong Ki Baeg, Seung Yeon Ko, Kyung-Do Han
      Scientific Reports.2016;[Epub]     CrossRef
    • The Relationship between Cancer Screening Rates and Promotional Methods in Incheon Metropolitan City
      Jong Doo Kim
      Health Policy and Management.2016; 26(4): 382.     CrossRef
    • Benefits and harms of endoscopic screening for gastric cancer
      Chisato Hamashima
      World Journal of Gastroenterology.2016; 22(28): 6385.     CrossRef
    • Strategies to improve treatment outcome in gastric cancer: A retrospective analysis of patients from two high-volume hospitals in Korea and China
      Kun Yang, Yoon Young Choi, Wei-Han Zhang, Xin-Zu Chen, Mi Kyung Song, Jinae Lee, Bo Zhang, Zhi-Xin Chen, Hyoung-Il Kim, Jia-Ping Chen, Jae-Ho Cheong, Zong-Guang Zhou, Woo Jin Hyung, Jian-Kun Hu, Sung Hoon Noh
      Oncotarget.2016; 7(28): 44660.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
      Cancer Res Treat. 2016;48(1):1-10.   Published online April 15, 2015
      Close
    • XML DownloadXML Download
    Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
    Image Image Image
    Fig. 1. Cancer screening rates with recommendation by sex, 2004-2013.
    Fig. 2. Cancer screening rates with recommendation by age (yr), 2004-2013.
    Fig. 3. Cancer screening rates with recommendation by household income level, 2004-2013. Monthly household income status classified by tertile.
    Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
    Cancer Target population Interval (yr) Test
    Stomach Aged ≥ 40 years 2 Upper endoscopy or UGIa)
    Liver High-risk groupb) aged ≥ 40 years 1 Ultrasonography and AFP
    Colorectal Aged ≥ 50 years 1 FOBTc)
    Breast Women aged ≥ 40 years 2 Mammography
    Cervix uteri Women aged ≥ 30 years 2 Pap smear
    Survey year
    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    Total 3,592 2,028 2,030 2,021 2,038 2,000 4,056 4,100 4,140 4,100
    Sex
     Male 42.4 41.0 40.2 39.4 40.6 41.0 41.4 41.9 42.0 42.3
     Female 57.6 59.0 59.8 60.6 59.4 59.1 58.6 58.1 58.0 57.7
    Age (yr)
     30-39a) 14.1 12.0 17.6 17.8 17.7 17.0 15.9 15.5 15.3 14.4
     40-49 35.9 41.1 34.6 34.8 35.5 35.6 34.9 33.7 33.5 33.0
     50-59 22.7 28.6 21.8 21.6 24.7 25.2 27.3 28.5 28.7 29.8
     60-69 17.3 15.6 19.1 21.9 16.4 16.4 16.8 16.1 16.2 16.8
     ≥ 70 10.2 2.7 6.9 3.9 5.8 5.9 5.2 6.2 6.4 6.0
    Education (yr)
     ≤ 8 25.8 16.4 20.9 18.2 13.6 15.1 8.1 8.2 9.7 5.2
     9-11 15.6 16.1 15.1 14.3 16.6 11.3 10.9 10.6 8.7 7.2
     12-15 34.3 47.6 44.7 46.3 46.6 46.8 52.1 52.5 50.6 54.1
     ≥ 16 22.6 18.5 17.6 19.1 20.7 24.9 28.8 28.7 30.9 33.5
    Monthly household incomeb) ($)c)
     ≤ 999 25.3 11.4 14.1 10.0 9.3 9.4 4.6 4.5 4.6 2.4
     1,000-2,999 39.0 57.1 53.1 50.5 48.8 45.0 37.6 37.8 33.3 22.5
     ≥ 3,000 18.8 29.7 29.9 38.7 40.3 44.5 57.7 57.7 62.0 75.1
    Marital status
     Married 88.2 92.8 89.6 89.8 90.3 90.2 91.5 91.5 94.2 91.8
     Not married 1.6 2.1 2.2 2.8 2.5 3.6 3.0 3.1 2.3 2.5
     Otherd) 9.5 5.1 8.3 7.4 7.2 6.3 5.5 5.5 3.6 5.7
    Residential area
     Metropolitan 46.8 47.4 47.4 47.5 46.5 46.6 44.3 45.2 44.4 44.3
     Urban 53.2e) 39.8 40.5 40.3 44.2 44.0 42.2 41.6 36.3 42.0
     Rural 12.7 12.1 12.2 9.3 9.4 13.5 13.1 19.4 13.6
    Health insurance typeb)
     National Health Insurance 90.8 95.8 94.5 96.7 95.9 95.3 96.5 96.7 98.3 96.9
     Medical Aid Program 6.0 4.2 4.2 3.2 3.8 4.3 3.5 3.3 1.7 3.1
    Survey year
    APC (95% CI)
    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    Lifetime screening rate (%)a)
     Stomach 52.0 48.5 53.5 55.3 65.0 65.1 76.7 76.2 77.9 80.0 3.9 (3.0 to 4.7)
     Liver 31.8 47.7 58.3 57.6 64.8 81.3 54.2 54.3 69.9 49.3 1.8 (-1.5 to 5.1)
     Colon and rectum 25.3 27.9 34.0 40.7 50.4 48.1 57.1 56.1 65.8 70.3 5.0 (4.3 to 5.7)
     Breast 55.9 57.4 60.2 66.4 72.7 78.1 79.5 79.0 82.9 83.1 3.4 (2.7 to 4.1)
     Cervix uteri 76.8 74.0 68.0 73.6 74.4 76.1 75.0 74.8 77.1 76.2 0.3 (-0.3 to 1.0)
    Screening rate with recommendation (%)b)
     Stomachc) 39.2 39.4 43.3 45.6 53.5 56.9 65.1 64.6 70.9 73.6 4.2 (3.7 to 4.8)
      Upper endoscopy 32.4 32.9 33.5 37.8 44.8 49.3 58.9 58.1 63.3 64.4 4.2 (3.4 to 4.9)
      UGI series 13.0 13.1 15.2 20.4 21.1 19.5 24.9 25.3 26.4 24.9 1.7 (1.3 to 2.1)
     Liverd) 20.0 16.3 16.5 22.7 19.7 31.3 22.9 22.9 21.5 33.6 1.2 (0.1 to 2.4)
     Colon and rectume) 19.9 25.4 29.4 34.1 37.9 36.7 35.5 35.3 44.7 55.6 3.0 (1.8 to 4.1)
      Colonoscopy 14.4 12.4 16.8 19.5 19.1 23.4 23.3 23.6 30.1 35.2 2.2 (1.6 to 2.8)
      DCBE 2.8 4.1 5.3 8.7 7.0 6.1 6.1 6.0 3.8 7.0 0.2 (-0.3 to 0.6)
      FOBT 3.8 7.2 13.6 20.2 20.9 19.0 25.9 25.0 29.6 27.6 2.7 (1.9 to 3.5)
     Breastf) 33.2 38.4 40.6 45.8 49.3 55.2 61.6 60.4 70.9 59.7 3.7 (2.7 to 4.8)
     Cervix uterig) 58.3 57.0 54.9 57.0 59.9 63.9 62.9 62.4 67.9 67.0 1.3 (0.8 to 1.8)
    Survey year
    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    Stomach Male 37.4 37.4 40.3 42.7 50.1 52.3 63.5 63.5 69.8 72.4
    Female 40.9 41.2 46.2 48.3 56.8 61.5 66.6 65.6 72.0 74.8
    40-49 36.8 34.2 37.0 39.3 47.3 47.3 59.6 59.1 65.1 72.6
    50-59 43.0 42.8 45.4 48.5 57.5 62.7 69.6 68.8 76.2 74.6
    60-69 43.6 47.0 54.5 53.6 59.6 69.5 69.9 69.0 75.0 74.4
    ≥ 70 31.0 38.9 37.9 40.5 57.6 55.6 62.2 63.6 67.7 72.2
    Colon and rectum Male 21.5 28.0 31.2 36.9 39.3 36.5 38.5 37.4 46.7 56.3
    Female 18.5 23.0 27.8 31.8 40.1 36.8 32.7 33.3 42.8 54.9
    50-59 19.4 23.5 26.0 30.7 40.0 35.5 33.3 32.7 42.9 54.7
    60-69 21.9 28.1 37.1 38.5 40.7 38.7 38.4 38.3 48.0 57.4
    ≥ 70 17.6 29.7 18.6 29.1 35.6 35.9 37.3 39.6 44.4 55.0
    Breast 40-49 37.6 35.8 40.7 44.2 42.1 51.0 59.4 57.4 69.0 63.8
    50-59 38.0 47.5 45.0 52.0 56.9 58.2 66.7 66.7 77.6 59.2
    60-69 30.5 33.0 44.5 46.5 51.1 65.5 59.1 58.1 68.5 56.5
    ≥ 70 15.6 16.7 20.9 25.5 54.4 38.8 51.9 54.0 59.6 50.8
    Cervix uteri 30-39 64.0 56.6 53.2 51.7 55.0 55.6 57.1 56.0 55.4 63.6
    40-49 70.5 62.4 64.0 66.7 60.1 70.8 67.2 66.6 75.1 72.6
    50-59 61.3 62.3 57.3 61.5 69.8 70.9 70.8 70.2 77.6 66.8
    60-69 38.1 39.7 53.1 51.2 57.9 64.9 58.8 58.3 65.2 64.7
    ≥ 70 27.9 25.0 26.4 38.3 54.4 41.8 45.7 47.9 54.1 62.0
    Table 1. Cancer screening protocols issued by the National Cancer Screening Program (NCSP) in Korea

    UGI, upper gastrointestinal series; AFP, alpha-fetoprotein; FOBT, fecal occult blood test.

    In the case of an abnormality on the UGI, endoscopy is recommended, and a biopsy is performed when an abnormality is found during endoscopy,

    Patients at high risk for liver cancer include those with chronic hepatitis determined by serological evidence of infection with hepatitis B or C virus or liver cirrhosis,

    In the case of an abnormality on FOBT, colonoscopy or a double-contrast barium enema is recommended, and a biopsy is performed when an abnormality is found during colonoscopy.

    Table 2. Distribution (%) of sociodemographic characteristics of the study respondents in the Korean National Cancer Screening Survey (KNCSS), 2004-2013

    Restricted to women aged 30-39 years,

    Some row sums are not 100% each year because of missing data,

    1 USD=1,000 KRW,

    Others: divorced or separated,

    The question related to residential area did not distinguish between urban and rural areas in 2004.

    Table 3. Cancer screening rates for five major cancers in Korea, 2004-2013

    APC, annual percent change; CI, confidence interval; UGI, upper gastrointestinal; DCBE, double-contrast barium enema; FOBT, fecal occult blood test.

    Lifetime screening rate was defined as the proportion of respondents who ever underwent the screening test(s),

    Screening rate with recommendation was defined as the proportion of respondents who fulfilled the screening recommendation criteria among the respondents in the targeted age group for the relevant cancer,

    Respondents were restricted to men and women ≥ 40 years of age who had last undergone upper endoscopy or UGI series screening within a period of 2 years,

    Respondents were restricted to men and women ≥ 40 years of age who were at high risk for liver cancer [hepatitis B virus surface antigen (+), hepatitis C virus antibody (+), or liver cirrhosis] who had last undergone screening with abdominal ultrasonography and serum alpha-fetoprotein within a period of 6 months,

    Respondents were restricted to men and women ≥ 50 years of age who had last undergone screening with colonoscopy, DCBE, or FOBT within a period of 10, 5, or 1 year, respectively. However, before 2009, patients who underwent colonoscopy within a period of 5 years were considered to have undergone screening with recommendation,

    Respondents were restricted to women ≥ 40 years of age who had last undergone screening with mammography within a period of 2 years,

    Respondents were restricted to women ≥ 30 years of age who had last undergone screening with conventional cytology within a period of 2 years.

    Table 4. Cancer screening rates with recommendation by sex and age, 2004-2013


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP